2025 Movement Disorders Symposium

Saturday, November 1, 2025, 7:30 AM - 5:00 PM PST, The Shay, 8801 Washington Blvd, Culver City, CA


Advancing Care in Parkinsons Disease and Beyond Parkinsons disease (PD) is not only the most common movement disorder but also the fastest-growing neurological condition worldwide. According to the Parkinsons Foundation, nearly one million people in the United States are currently living with PD, with approximately 60,000 new cases diagnosed each year. However, PD is just one of several movement disorders that pose significant clinical challenges. Other conditions, such as essential tremor, dystonia, Huntingtons disease, and atypical parkinsonian syndromes, also require specialized and evolving approaches to care. Given the complexity and heterogeneity of these disorders particularly Parkinsons disease clinicians must tailor management strategies to each individual patient. To meet this demand, expert faculty will explore the latest advances in the diagnosis and treatment of movement disorders, with a special focus on PD. Topics will include both established and emerging medical and surgical interventions designed to slow disease progression, manage symptoms, and enhance quality of life. The program will also address the broad spectrum of motor and non-motor symptoms that impact patients, as well as the role of nutritional, lifestyle, and psychosocial factors in comprehensive care. Through in-depth discussion, healthcare professionals will gain valuable insights and practical strategies for improving outcomes across the spectrum of movement disorders. This educational activity is designed for a multidisciplinary audience, including neurologists, neurosurgeons, psychiatrists, physiatrists (PM&R), general practitioners, and internists. It will also be highly relevant to nurses, nurse practitioners, physician assistants, allied health professionals, as well as neurology residents and fellows. Other healthcare providers involved in the care of patients with Parkinsons disease and related movement disorders will also benefit from attending.

1. Recognize the clinical presentation, management and progression of Parkinsons disease and other movement disorders
2. Assess available therapies for the management of motor and nonmotor symptoms of Parkinsons disease dystonia and essential tremor
3. Evaluate ongoing and emerging research in Parkinsons disease and the implications for emerging therapeutic options
4. Guide patients and caregivers in making key treatment decisions in Parkinsons disease or other movement disorders.

REGISTRATION COMING SOON!

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 7.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (7.00 hours), Non-Physician AMA Attendance (7.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.